One and a Half Million Hematopoietic Stem Cell Transplants: Continuous and Differential Improvement in Worldwide Access With the Use of Non-Identical Family Donors

One and a Half Million Hematopoietic Stem Cell Transplants: Continuous and Differential Improvement in Worldwide Access With the Use of Non-Identical Family Donors Publisher Pubmed

Niederwieser D^{1, 2, 3} ; Baldomero H⁴ ; Bazuaye N^{5, 6} ; Bupp C⁷ ; Chaudhri N^{8, 9} ; Corbacioglu S^{10, 11} ; Elhaddad A^{5, 12} ; Frutos C^{13, 14} ; Galeano S^{13, 15} ; Hamad N^{16, 17} ; Hamidieh AA^{8, 18} ; Hashmi S^{19, 20} ; Ho A^{21, 22} ; Horowitz MM²³ Show All Authors

Niederwieser D^{1, 2, 3}
Baldomero H⁴
Bazuaye N^{5, 6}
Bupp C⁷
Chaudhri N^{8, 9}
Corbacioglu S^{10, 11}
Elhaddad A^{5, 12}
Frutos C^{13, 14}
Galeano S^{13, 15}
Hamad N^{16, 17}
Hamidieh AA^{8, 18}
Hashmi S^{19, 20}
Ho A^{21, 22}
Horowitz MM²³
Iida M^{21, 24}
Jaimovich G^{13, 25}
Karduss A^{13, 26}
Kodera Y^{21, 24}
Kroger N^{10, 27}
De Latour RP^{10, 28}
Lee JW^{21, 29}
Martinezrolon J^{13, 30}
Pasquini MC²³
Passweg J^{10, 31}
Paulson K³²
Seber A^{13, 33}
Snowden JA^{10, 34}
Srivastava A^{21, 35}
Szer J^{16, 36}
Weisdorf D^{7, 37}
Worel N³⁸
Koh MBC^{39, 40}
Aljurf M^{8, 41}
Greinix H⁴²
Atsuta Y^{21, 43}
Saber W²³

Source: Haematologica Published:2022

Abstract

The Worldwide Network of Blood and Marrow Transplantation (WBMT) pursues the mission of promoting hematopoietic cell transplantation (HCT) for instance by evaluating activities through member societies, national registries and individual centers. In 2016, 82,718 first HCT were reported by 1,662 HCT teams in 86 of the 195 World Health Organization member states representing a global increase of 6.2% in autologous HCT and 7.0% in allogeneic HCT and bringing the total to 1,298,897 procedures. Assuming a frequency of 84,000/year, 1.5 million HCT were performed by 2019 since 1957. Slightly more autologous (53.5%) than allogeneic and more related (53.6%) than unrelated HCT were reported. A remarkable increase was noted in haploidentical related HCT for leukemias and lymphoproliferative diseases, but even more in non-malignant diseases. Transplant rates (TR; HCT/10 million population) varied according to region reaching 560.8 in North America, 438.5 in Europe, 76.7 in Latin America, 53.6 in South East Asia/Western Pacific (SEA/WPR) and 27.8 in African/East Mediterranean (AFR/EMR). Interestingly, haploidentical TR amounted to 32% in SEA/WPR and 26% in Latin America, but only 14% in Europe and EMR and 4.9% in North America of all allogeneic HCT. HCT team density (teams/10 million population) was highest in Europe (7.7) followed by North America (6.0), SEA/WPR (1.9), Latin America (1.6) and AFR/EMR (0.4). HCT are increasing steadily worldwide with narrowing gaps between regions and greater increase in allogeneic compared to autologous activity. While related HCT is rising, largely due to increase in haploidentical HCT, unrelated HCT is plateauing and cord blood HCT is in decline. 2022 Ferrata Storti Foundation

Related Docs

View other Related Docs

1. Narrowing the Gap for Hematopoietic Stem Cell Transplantation in the East-Mediterranean/African Region: Comparison With Global Hsct Indications and Trends, Bone Marrow Transplantation (2019)

2. Strategic Priorities for Hematopoietic Stem Cell Transplantation in the Emro Region, Hematology/ Oncology and Stem Cell Therapy (2023)

3. Advances in Hematopoietic Stem Cell Transplantation in the Asia-Pacific Region: The Second Report From Apbmt 2005–2015, Bone Marrow Transplantation (2019)

Experts (# of related papers)

View all Related Experts

Amir Ali Hamidieh (9)

Maryam Barkhordar (3)

Style	Citing Format
MLA	Niederwieser D, et al.. "One and a Half Million Hematopoietic Stem Cell Transplants: Continuous and Differential Improvement in Worldwide Access With the Use of Non-Identical Family Donors." Haematologica, vol. 107, no. 5, 2022, pp. 1045-1053.
APA	Niederwieser D, Baldomero H, Bazuaye N, Bupp C, Chaudhri N, Corbacioglu S, Elhaddad A, Frutos C, Galeano S, Hamad N, Hamidieh AA, Hashmi S, Ho A, Horowitz MM, Iida M, Jaimovich G, Karduss A, Kodera Y, Kroger N, ... Saber W (2022). One and a Half Million Hematopoietic Stem Cell Transplants: Continuous and Differential Improvement in Worldwide Access With the Use of Non-Identical Family Donors. Haematologica, 107(5), 1045-1053.
Chicago	Niederwieser D, Baldomero H, Bazuaye N, Bupp C, Chaudhri N, Corbacioglu S, Elhaddad A, et al.. "One and a Half Million Hematopoietic Stem Cell Transplants: Continuous and Differential Improvement in Worldwide Access With the Use of Non-Identical Family Donors." Haematologica 107, no. 5 (2022): 1045-1053.
Harvard	Niederwieser D et al. (2022) 'One and a Half Million Hematopoietic Stem Cell Transplants: Continuous and Differential Improvement in Worldwide Access With the Use of Non-Identical Family Donors', Haematologica, 107(5), pp. 1045-1053.
Vancouver	Niederwieser D, Baldomero H, Bazuaye N, Bupp C, Chaudhri N, Corbacioglu S, et al.. One and a Half Million Hematopoietic Stem Cell Transplants: Continuous and Differential Improvement in Worldwide Access With the Use of Non-Identical Family Donors. Haematologica. 2022;107(5):1045-1053.
BibTex	@article{ author = {Niederwieser D and Baldomero H and Bazuaye N and Bupp C and Chaudhri N and Corbacioglu S and Elhaddad A and Frutos C and Galeano S and Hamad N and Hamidieh AA and Hashmi S and Ho A and Horowitz MM and Iida M and Jaimovich G and Karduss A and Kodera Y and Kroger N and De Latour RP and Lee JW and Martinezrolon J and Pasquini MC and Passweg J and Paulson K and Seber A and Snowden JA and Srivastava A and Szer J and Weisdorf D and Worel N and Koh MBC and Aljurf M and Greinix H and Atsuta Y and Saber W}, title = {One and a Half Million Hematopoietic Stem Cell Transplants: Continuous and Differential Improvement in Worldwide Access With the Use of Non-Identical Family Donors}, journal = {Haematologica}, volume = {107}, number = {5}, pages = {1045-1053}, year = {2022} }
RIS	TY - JOUR AU - Niederwieser D AU - Baldomero H AU - Bazuaye N AU - Bupp C AU - Chaudhri N AU - Corbacioglu S AU - Elhaddad A AU - Frutos C AU - Galeano S AU - Hamad N AU - Hamidieh AA AU - Hashmi S AU - Ho A AU - Horowitz MM AU - Iida M AU - Jaimovich G AU - Karduss A AU - Kodera Y AU - Kroger N AU - De Latour RP AU - Lee JW AU - Martinezrolon J AU - Pasquini MC AU - Passweg J AU - Paulson K AU - Seber A AU - Snowden JA AU - Srivastava A AU - Szer J AU - Weisdorf D AU - Worel N AU - Koh MBC AU - Aljurf M AU - Greinix H AU - Atsuta Y AU - Saber W TI - One and a Half Million Hematopoietic Stem Cell Transplants: Continuous and Differential Improvement in Worldwide Access With the Use of Non-Identical Family Donors JO - Haematologica VL - 107 IS - 5 SP - 1045 EP - 1053 PY - 2022 ER -

Style

Citing Format

MLA

Niederwieser D, et al.. "One and a Half Million Hematopoietic Stem Cell Transplants: Continuous and Differential Improvement in Worldwide Access With the Use of Non-Identical Family Donors." Haematologica, vol. 107, no. 5, 2022, pp. 1045-1053.

APA

Niederwieser D, Baldomero H, Bazuaye N, Bupp C, Chaudhri N, Corbacioglu S, Elhaddad A, Frutos C, Galeano S, Hamad N, Hamidieh AA, Hashmi S, Ho A, Horowitz MM, Iida M, Jaimovich G, Karduss A, Kodera Y, Kroger N, ... Saber W (2022). One and a Half Million Hematopoietic Stem Cell Transplants: Continuous and Differential Improvement in Worldwide Access With the Use of Non-Identical Family Donors. Haematologica, 107(5), 1045-1053.

Chicago

Niederwieser D, Baldomero H, Bazuaye N, Bupp C, Chaudhri N, Corbacioglu S, Elhaddad A, et al.. "One and a Half Million Hematopoietic Stem Cell Transplants: Continuous and Differential Improvement in Worldwide Access With the Use of Non-Identical Family Donors." Haematologica 107, no. 5 (2022): 1045-1053.

Harvard

Niederwieser D et al. (2022) 'One and a Half Million Hematopoietic Stem Cell Transplants: Continuous and Differential Improvement in Worldwide Access With the Use of Non-Identical Family Donors', Haematologica, 107(5), pp. 1045-1053.

Vancouver

Niederwieser D, Baldomero H, Bazuaye N, Bupp C, Chaudhri N, Corbacioglu S, et al.. One and a Half Million Hematopoietic Stem Cell Transplants: Continuous and Differential Improvement in Worldwide Access With the Use of Non-Identical Family Donors. Haematologica. 2022;107(5):1045-1053.

BibTex

@article{ author = {Niederwieser D and Baldomero H and Bazuaye N and Bupp C and Chaudhri N and Corbacioglu S and Elhaddad A and Frutos C and Galeano S and Hamad N and Hamidieh AA and Hashmi S and Ho A and Horowitz MM and Iida M and Jaimovich G and Karduss A and Kodera Y and Kroger N and De Latour RP and Lee JW and Martinezrolon J and Pasquini MC and Passweg J and Paulson K and Seber A and Snowden JA and Srivastava A and Szer J and Weisdorf D and Worel N and Koh MBC and Aljurf M and Greinix H and Atsuta Y and Saber W}, title = {One and a Half Million Hematopoietic Stem Cell Transplants: Continuous and Differential Improvement in Worldwide Access With the Use of Non-Identical Family Donors}, journal = {Haematologica}, volume = {107}, number = {5}, pages = {1045-1053}, year = {2022} }

RIS

TY - JOUR
AU - Niederwieser D
AU - Baldomero H
AU - Bazuaye N
AU - Bupp C
AU - Chaudhri N
AU - Corbacioglu S
AU - Elhaddad A
AU - Frutos C
AU - Galeano S
AU - Hamad N
AU - Hamidieh AA
AU - Hashmi S
AU - Ho A
AU - Horowitz MM
AU - Iida M
AU - Jaimovich G
AU - Karduss A
AU - Kodera Y
AU - Kroger N
AU - De Latour RP
AU - Lee JW
AU - Martinezrolon J
AU - Pasquini MC
AU - Passweg J
AU - Paulson K
AU - Seber A
AU - Snowden JA
AU - Srivastava A
AU - Szer J
AU - Weisdorf D
AU - Worel N
AU - Koh MBC
AU - Aljurf M
AU - Greinix H
AU - Atsuta Y
AU - Saber W
TI - One and a Half Million Hematopoietic Stem Cell Transplants: Continuous and Differential Improvement in Worldwide Access With the Use of Non-Identical Family Donors
JO - Haematologica
VL - 107
IS - 5
SP - 1045
EP - 1053
PY - 2022
ER -

Science Communicator Platform

Authors

Abstract